Variant report
Variant | esv3436647 |
---|---|
Chromosome Location | chr5:1922652-1927150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: | |
2 | chr5:1914837..1916818-chr5:1921898..1924195,2 | K562 | blood: | |
3 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: | |
4 | chr5:1920038..1922611-chr5:1924901..1927373,2 | MCF-7 | breast: | |
5 | chr5:1923598..1926065-chr5:2006441..2007973,2 | K562 | blood: | |
6 | chr5:1923560..1925350-chr5:1937042..1939475,2 | MCF-7 | breast: | |
7 | chr5:1918788..1920999-chr5:1921103..1923606,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574822054 | chr5:1922726-1922727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6555026 | chr5:1922758-1922759 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs565787421 | chr5:1922786-1922787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576258782 | chr5:1922787-1922788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190470983 | chr5:1922794-1922795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6420032 | chr5:1922802-1922803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs565093542 | chr5:1922808-1922809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532331818 | chr5:1922823-1922824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547545380 | chr5:1922828-1922829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559489413 | chr5:1922845-1922846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144636799 | chr5:1922868-1922869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6420033 | chr5:1922870-1922871 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs376673195 | chr5:1922877-1922878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147893383 | chr5:1922895-1922896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35998327 | chr5:1922911-1922912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537367816 | chr5:1922951-1922952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141652280 | chr5:1922964-1922965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570305009 | chr5:1923003-1923004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534885944 | chr5:1923090-1923091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537378163 | chr5:1923091-1923092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142922712 | chr5:1923169-1923170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs151098550 | chr5:1923175-1923176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547932994 | chr5:1923198-1923199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535894096 | chr5:1923293-1923294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566142912 | chr5:1923314-1923315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557096413 | chr5:1923337-1923338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559217641 | chr5:1923378-1923379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543776775 | chr5:1923390-1923391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10462748 | chr5:1923467-1923468 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs114494849 | chr5:1923490-1923491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141084897 | chr5:1923520-1923521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559548225 | chr5:1923546-1923547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182707154 | chr5:1923547-1923548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6865197 | chr5:1923557-1923558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112827491 | chr5:1923585-1923586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139022814 | chr5:1923600-1923601 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188182238 | chr5:1923615-1923616 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570799382 | chr5:1923628-1923629 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs367722287 | chr5:1923644-1923645 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534943264 | chr5:1923654-1923655 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546790400 | chr5:1923668-1923669 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111464544 | chr5:1923672-1923673 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542410241 | chr5:1923676-1923677 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535590853 | chr5:1923679-1923680 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560954345 | chr5:1923706-1923707 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557413672 | chr5:1923709-1923710 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144606096 | chr5:1923722-1923723 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138588439 | chr5:1923725-1923726 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558936397 | chr5:1923743-1923744 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115160305 | chr5:1923745-1923746 | Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1917200-1923800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:1923600-1924400 | Bivalent/Poised TSS | Hela-S3 | cervix |
3 | chr5:1923800-1924000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr5:1923800-1924400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:1924200-1928000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:1924400-1925600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr5:1925600-1926400 | ZNF genes & repeats | Right Atrium | heart |
8 | chr5:1925600-1927600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:1925800-1926400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
10 | chr5:1926000-1926200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
11 | chr5:1926200-1929200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr5:1926400-1929200 | Weak transcription | Right Atrium | heart |
13 | chr5:1926600-1927200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
14 | chr5:1926800-1927000 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr5:1927000-1928000 | Weak transcription | H1 Cell Line | embryonic stem cell |